Search results
Sarepta Therapeutics gains as Pfizer failure removes overhang
Investing.com· 17 hours agoSarepta Therapeutics gains as Pfizer failure removes overhang
Sarepta’s stock gains after Pfizer’s Duchenne trial failure - Boston Business Journal
The Business Journals· 7 hours agoPharma giant Pfizer Inc. (NYSE: PFE) announced on Wednesday after markets closed that its gene...
Pfizer Provides Update on Phase 3 Study of Investigational Gene Therapy for Ambulatory Boys with...
Morningstar· 1 day agoPfizer Inc. (NYSE: PFE) today announced that CIFFREO, a Phase 3 global, multicenter, randomized, double-blind, placebo-controlled study evaluating the investigational mini-dystrophin ...
Pfizer's phase 3 gene therapy trial fails to improve function for boys with Duchenne muscular...
FierceBiotech· 1 day agoPfizer’s phase 3 gene therapy trial has failed to demonstrate significant improvement in motor...
Flagship Pioneering and ProFound link for obesity therapies
Pharmaceutical Technology via Yahoo Finance· 11 hours agoThe collaboration marks the first initiative executed under Flagship’s Pioneering Medicines deal...
Pfizer, Flagship name first target for multibillion-dollar collaboration: obesity
FierceBiotech· 1 day agoPfizer and Flagship Pioneering have settled on the first target for their billion-dollar,...
The FDA Could, Finally, Approve Novavax's Covid Vaccine — Is Novavax Stock A Buy?
Investor's Business Daily· 2 hours agoSince then, the stock has trended lower. The vaccine is based on protein technology, differentiating...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 2 hours agoBiotech stock hit a two-year high in February, but have trended sideways in the months since despite...
Thinking Of Buying Pfizer For Its 5.8% Dividend Yield? Consider This Alternative Option Instead
Benzinga via Yahoo Finance· 6 days agoPfizer Inc. (NYSE:PFE) has long been a favorite among income investors, thanks to its generous...
Pfizer's gene therapy for a muscle-wasting disorder misses main goal of late-stage study
Reuters· 1 day ago, opens new tab said on Wednesday its experimental gene therapy for a type of muscle-wasting...